Winning PTAB Args Should Be OK For Court, Fed. Circ. Hears
Warning of high drug prices and a destabilization of America Invents Act reviews, the generic drug industry's top trade group urged the Federal Circuit on Friday not to adopt the view...To view the full article, register now.
Already a subscriber? Click here to view full article